Salwan Al-Nasiry

Salwan Al-Nasiry

Auto-generated profile, based on publicly available information

Salwan Al-Nasiry

Department of Obstetrics and Gynaecology Maastricht University Medical Center Maastricht The Netherlands

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2007 in Human Reproduction
Verified
Journal Article
Open access
PDF file
SAS. Al-Nasiry
S. Al-Nasiry
NGN. Geusens
N. Geusens
MHM. Hanssens
M. Hanssens
CLC. Luyten
C. Luyten
RPR. Pijnenborg
R. Pijnenborg
The current techniques for quantifying trophoblast viability, migration and invasion are mainly limited by the need to sacrifice the cells during the test procedure. In this study, the vital dye AB (AB) was used to quantify cell number and viability of BeWo and JEG-3 choriocarcinoma cells, as well as their migration and invasion through fibronectin-coated filters. AB was directly added to culture medium of incubated test and control cells. At various time intervals, the redox reaction, in which AB is reduced by the cells, was measured by absorbance readings at 540 and 630 nm. For cell migration and invasion, cells were cultured onto uncoated or fibronectin-coated inserts, respectively. AB reduction of migrated cells was normalized to that of control cells to calculate percentages of migration. This model was also tested in the presence of a reported inhibitor, transforming growth factor (TGF) β. The curve of %AB reduction versus cell number was linear, with intra- and inter-assay Coefficient of Variations of 1.88%and 2.94%, respectively. AB reduction increased with both seeding concentrations and incubation time with AB. TGFβ treatment caused a modest decrease in AB reduction in both JEG-3 and BeWo cells. TGFβ treatment also decreased migration in BeWo, but not in JEG-3, cells. AB assay is a simple and reliable method for quantifying trophoblast viability, migration and invasion.

6 October 2005 in Human Reproduction
Verified
Journal Article
Open access
PDF file
SAS. Al-Nasiry
S. Al-Nasiry
BSB. Spitz
B. Spitz
MHM. Hanssens
M. Hanssens
CLC. Luyten
C. Luyten
RPR. Pijnenborg
R. Pijnenborg
BACKGROUND: The interactions of trophoblasts with the cytokine network at the fetomaternal interface determine the pathway the cell undertakes, e.g. proliferation, differentiation and apoptosis. METHODS: We used cultures of fusigenic BeWo and non-fusigenic JEG-3 choriocarcinoma cells to study the effects of inducers of syncytialisation (forskolin) and apoptosis [tumour necrosis factor-α (TNFα)] on differentiation, viability, proliferation and apoptosis. RESULTS: E-cadherin immunostaining showed that syncytium formation was confined to BeWo and not JEG-3 cells, while secretion of hCG was promoted by forskolin in both cell types implying a ‘dissociation’ between morphological and biochemical differentiation. Forskolin also had differential effects on cell viability (MTT reduction test) and proliferation (Ki67 immunostaining with MIB-1 monoclonal antibody), both decreasing in BeWo and increasing in JEG-3 cells. TNFα increased apoptosis (cytokeratin neo-epitope immunostaining with M30 monoclonal antibody) in both cell types, an effect which was blocked by epidermal growth factor selectively in JEG-3 cells. CONCLUSION: Our results suggest that the differential responses of BeWo and JEG-3 cells to inducers of syncytialization and apoptosis might be related to their fusigenic capacity. Caution is needed when extrapolating results obtained by these models to normal trophoblast populations. However, we speculate that these models can help identify key factors involved in trophoblast differentiation at the placental bed.

8 January 2020 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
PDF file
GHGf Hasperhoven
Gf Hasperhoven
SAS Al‐Nasiry
S Al‐Nasiry
VBV Bekker
V Bekker
EVE Villamor
E Villamor
BKBww Kramer
Bww Kramer
Background: Early‐onset group B streptococcal (EOGBS) disease (including sepsis, meningitis, and pneumonia) causes significant morbidity and mortality in newborn infants worldwide. Antibiotic prophylaxis can prevent vertical streptococcal transmission, yet no uniform criteria exist to identify eligible women for prophylaxis. Some guidelines recommend universal GBS screening to pregnant women in their third trimester (screening‐based protocol), whereas others employ risk‐based protocols.Objectives: To compare the effectiveness of screening‐based versus risk‐based protocols in preventing EOGBS disease.Search strategy: Key words for the database searches included GBS, Streptococcus agalactiae, pregnancy, screening, culture‐based, risk‐based. Selection criteria: Studies were included if they investigated EOGBS disease incidence in newborn infants and compared screening or risk‐based protocols with each other or with controls.Data collection and analysis: Risk ratios (RR) and 95% confidence intervals (CI) were determined using Mantel‐Haenszel analyses with random effects.Main results: Seventeen eligible studies were included. In this meta‐analysis, screening was associated with a reduced risk for EOGBS disease compared either with risk‐based protocols (ten studies, RR 0.43, 95% CI 0.32–0.56) or with no policy (four studies, RR 0.31, 95% CI 0.11–0.84). Meta‐analysis could not demonstrate a significant effect of risk‐based protocols versus no policy (seven studies, RR 0.86, 95% CI 0.61–1.20). In studies reporting on the use of antibiotics, screening was not associated with higher antibiotic administration rates (31 versus 29%).Conclusions: Screening‐based protocols were associated with lower incidences of EOGBS disease compared with risk‐based protocols, while not clearly overexposing women to antibiotics. This information is of relevance for future policymaking.Tweetable Meta‐analysis: general screening is associated with lower rates of early‐onset group B strep. neonatal sepsis compared with risk‐based protocols.

1 September 2013 in Placenta
Verified
Journal Article
Closed access
DSD.U. Stevens
D.U. Stevens
SAS. Al-Nasiry
S. Al-Nasiry
JBJohan Bulten
Johan Bulten
MSM.E.A. Spaanderman
M.E.A. Spaanderman

12 January 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Philippe VangriekenPhilippe Vangrieken
Philippe Vangrieken
SASalwan Al-Nasiry
Salwan Al-Nasiry
ABAalt Bast
Aalt Bast
PLPieter A. Leermakers
Pieter A. Leermakers
CTChristy B. M. Tulen
Christy B. M. Tulen
ARAlex H. V. Remels
Alex H. V. Remels
Introduction: Impaired utero-placental perfusion is a well-known feature of early preeclampsia and is associated with placental hypoxia and oxidative stress. Although aberrations at the level of the mitochondrion have been implicated in PE pathophysiology, whether or not hypoxia-induced mitochondrial abnormalities contribute to placental oxidative stress is unknown. Methods: We explored whether abnormalities in mitochondrial metabolism contribute to hypoxia-induced placental oxidative stress by using both healthy term placentae as well as a trophoblast cell line (BeWo cells) exposed to hypoxia. Furthermore, we explored the therapeutic potential of the antioxidants MitoQ and quercetin in preventing hypoxia-induced placental oxidative stress. Results: Both in placental explants as well as BeWo cells, hypoxia resulted in reductions in mitochondrial content, decreased abundance of key molecules involved in the electron transport chain and increased expression and activity of glycolytic enzymes. Furthermore, expression levels of key regulators of mitochondrial biogenesis were decreased while the abundance of constituents of the mitophagy, autophagy and mitochondrial fission machinery was increased in response to hypoxia. In addition, placental hypoxia was associated with increased oxidative stress, inflammation, and apoptosis. Moreover, experiments with MitoQ revealed that hypoxia-induced reactive oxygen species originated from the mitochondria in the trophoblasts. Discussion: This study is the first to demonstrate that placental hypoxia is associated with mitochondrial-generated reactive oxygen species and significant alterations in the molecular pathways controlling mitochondrial content and function. Furthermore, our data indicate that targeting mitochondrial oxidative stress may have therapeutic benefit in the management of pathologies related to placental hypoxia.

1 August 2012 in Placenta
Verified
Journal Article
Closed access
DSD.U. Stevens
D.U. Stevens
SAS. Al-Nasiry
S. Al-Nasiry
JBJohan Bulten
Johan Bulten
MSM.E.A. Spaanderman
M.E.A. Spaanderman